Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Securisyn Medical is a medical technology company dedicated to enhancing patient safety through innovative airway and medical tube stabilization systems. The company's flagship product, the SolidAIRity III Airway Stabilization System, is an FDA 510(k) cleared device designed to prevent unplanned extubation (UE) in ventilated patients by providing superior tube securement compared to traditional tape or tube holders. Securisyn's portfolio also includes the SolidAIRity Flex for adults and upcoming pediatric and neonatal versions, as well as the Sentry CT for chest tube securement. By utilizing its patented Interlock™ Securement System, the company aims to reduce preventable deaths, complications like ventilator-associated pneumonia, and the significant healthcare costs associated with tube dislodgement. Securisyn collaborates with major institutions such as the Mayo Clinic and the U.S. Air Force to develop ruggedized and specialized solutions for both hospital and field environments. The company has established a strategic partnership with SunMed Group Holdings for the global manufacturing and distribution of its airway securement technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Securisyn Medical.